Can a simple test predict lung Cancer's return? new study seeks answers

NCT ID NCT05557474

Recruiting now Knowledge-focused Sponsor: Chung Shan Medical University Source: ClinicalTrials.gov ↗

First seen Feb 26, 2026 · Last updated May 22, 2026 · Updated 10 times

Summary

This study is developing and testing two new kits that aim to predict if early-stage lung cancer will come back after surgery. Researchers will use protein markers from tumor samples and blood tests to identify high-risk patients. The goal is to help doctors decide who needs more aggressive follow-up or treatment. About 236 adults with stage IA to IIIA lung adenocarcinoma who had complete tumor removal will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Chung Shan Medical University Hospital
RECRUITING

Taichung, Taiwan, 402, Taiwan

Contact Phone: •••-•••-•••• Email: •••••@•••••
National Taiwan University, Cancer Center
RECRUITING

Taipei, 106, Taiwan

Contact

Conditions

Explore the condition pages connected to this study.

LUNG CANCER RECURRENCE SURGERY